FDA Commissioner Marty Makary: Tylenol, Vaccines & Autism + Fauci, NIH & COVID-19 | PBD Podcast | Ep. 690

Key Takeaways

FDA Commissioner details agency achievements, food supply, and disease cure priorities.
Dr. Makary criticizes Fauci's COVID-19 response and theorizes on virus lab origins.
Concerns raised about COVID-19 vaccine safety, potential long-term effects, and information suppression.
Pharmaceutical profits and drug development incentives conflict with accessible, life-saving cures.
Debate on drug patent reform aims to balance innovation with affordability amid lobbying.
HRT's re-evaluation and the concerning, environmentally linked trend of earlier female puberty.
Eugenics history and modern public health controversies, including gender identity and disease origins.
Public health communication criticized for political correctness and avoiding sensitive data.
Research links prenatal Tylenol use to autism; claims of donor pressure influenced retractions.
Corrupted nutrition science and ultra-processed foods drive reform efforts in food policy.

FDA Commissioner Makary discussed his eight months in office, highlighting achievements like eliminating unnecessary animal testing and removing petroleum-based food dyes.
The guest stated friends' top concerns include improving the food supply and finding cures for diseases, particularly specific cancers and neurodegenerative conditions.
Efforts are underway to reform the food pyramid, making it more concise and correcting past dietary dogma, moving away from previous 'war on saturated fat'.
Public trust in health institutions is discussed, emphasizing honesty and direct communication, noting 40% of children have chronic diseases.

The guest alleged Dr. Anthony Fauci misled the public on COVID-19, citing inconsistencies in early guidance and a lack of specific infectious disease fellowship training.
The possibility of COVID-19 originating from the Wuhan lab was discussed, referencing a 2018 grant proposal for genetically modifying bat coronaviruses.
Criticism was directed at Fauci and Collins for allegedly circumventing a presidential moratorium on gain-of-function research and continuing its funding.
The guest suggested Fauci employed linguistic maneuvering and inconsistency regarding school closures and advice against shaking hands.

The guest noted challenges in identifying long-term vaccine effects and stated risks for young, healthy individuals from COVID-19 were minimal, a fact allegedly downplayed.
Concerns were raised about vaccine injuries being misattributed to long COVID, with specific mention of myocarditis data held by the FDA and CDC.
The discussion highlighted alleged censorship of vaccine complication stories by platforms like Facebook and the White House.
Speculation arose regarding a link between vaccines and athletes experiencing medical emergencies, with reference to DeMar Hamlin's undisclosed condition.

Discussion touched on the economics of drug development, noting new biologics yield significant profits due to market exclusivity, unlike generic repurposing.
A significant price reduction for GLP-1 medications from $1,300 to a $50 or $150 copay was mentioned, indicating massive shifts in drug costs.
The conversation explored the potential conflict between pharmaceutical profit motives and developing cures, citing hypothetical scenarios where a cure could drastically reduce revenue.
A new cancer treatment that melts away tumors is undergoing priority review at the FDA, with expectations to avert surgeries and chemotherapy.

Pharmaceutical companies typically have a 20-year patent, often extended through legal means, leading to high initial prices before generic competition.
The host argued against disrupting free market incentives for innovation in pharmaceuticals, citing potential catastrophic outcomes.
A proposed reform suggests inventors receive a percentage of profits from generic versions for a limited time after patent expiration.
The FDA Commissioner noted such changes require congressional action, referencing existing patent reform bills and significant pharmaceutical lobbying efforts, estimated at $710 million in 2020.

The discussion critically examined the demonization of hormone replacement therapy (HRT) for postmenopausal women, attributed to a misinterpretation of a 2002 NIH study.
HRT is presented as a life-changing treatment offering significant long-term health benefits, including a 25-50% reduction in fatal heart attacks and prevention of osteoporosis.
The optimal window for initiating HRT is generally within 10 years of menopause or before age 60.
The age of female puberty has declined historically, from 16-17 in the late 1800s to around 11 years today, with some girls showing signs as early as six or seven.

The conversation touched on the history of the eugenics movement in the U.S. during the early 1900s, targeting poor and minority populations.
Modern social issues were criticized, including the use of puberty blockers for children and debates around transgender rights, citing a biological male winning a women's strongest competition.
The origins of diseases like AIDS and Empox were questioned, suggesting potential lab origins, referencing Dr. Anthony Fauci.
The guest proposed a lab origin for Lyme disease at Plum Island, New York, citing the book 'Bitten' and recounting finding bizarre animal carcasses in Montauk in the 1990s.

The host used the origin of AIDS from monkeys and its disproportionate impact as an example of needing to analyze data without political correctness.
Criticism was directed at the CDC's renaming of monkeypox to 'Empox' and their delay in labeling it a sexually transmitted infection.
The host argued that political correctness and fear of stigma prevent honest public communication about health risks.
Discussion highlighted difficulty in stating that multiple sexual partners can increase the risk of STDs, questioning WHO advice on monkeypox.

The guest introduced research on Tylenol's potential links to autism, noting it is a priority for the current administration.
The dean of the Harvard School of Public Health allegedly stated a causal relationship between prenatal acetaminophen use and neurodevelopmental disorders like ADHD and autism.
Concerns were raised about Tylenol overuse, and the precautionary principle was advocated for minimizing its use during pregnancy.
The guest claimed the Harvard Dean retracted his statement regarding Tylenol and autism due to donor pressure, leading to a 'watering down' of the message.

Global food health rankings identified Japan and Mediterranean regions as healthiest, while the U.S., UK, and Australia were among the least healthy due to processed foods.
Nutrition science was described as historically corrupted by flawed studies, industry funding, and the influence of figures like Dr. Ansel Keys promoting refined carbohydrates.
The 'Generally Recognized As Safe' (GRAS) rule, which allowed chemicals in food without rigorous testing, is being undone by the current administration.
Reforms include front-of-package labeling for added sugars and a unified definition for ultra-processed foods, aiming to address obesity as a 'glycemic addiction'.